Chronic myeloid leukaemia - asciminib or ponatinib - continuing authority application form (PB084)

Use this form to apply to continue PBS-subsidised treatment with asciminib or ponatinib for chronic myeloid leukaemia.

Page last updated: 17 June 2024.
QC 21456